Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2026
Rapid Access to Photoswitchable RNA Binders: Fluorination Enhances Protein Rescue by Exon InclusionLei Zhang, Nemanja Djokovic, Alexander Herr, et al.Molecular Informatics|March 31, 2021
An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseNemanja Djokovic, Dusan Ruzic, Teodora Djikic, et al.European Journal of Medicinal Chemistry|February 18, 2014
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's diseaseOscar M Bautista-Aguilera, Gerard Esteban, Irene Bolea, et al.Drug Design, Development and Therapy|November 8, 2014
Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybridsOscar M Bautista-Aguilera, Gerard Esteban, Mourad Chioua, et al.Pharmaceutics|December 23, 2022
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological EvaluationDusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, et al.Molecules (Basel, Switzerland)|April 17, 2019
Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-TargetsStrahinja Stevanovic, Milan Sencanski, Mathieu Danel, et al.Molecules (Basel, Switzerland)|September 10, 2021
Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L ProteinCorentin Bon, Yang Si, Melanie Pernak, et al.Progress in Neurobiology|January 23, 2016
Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's diseaseLhassane Ismaili, Bernard Refouvelet, Mohamed Benchekroun, et al.Journal of Computer-Aided Molecular Design|November 27, 2014
Predicting targets of compounds against neurological diseases using cheminformatic methodologyKatarina Nikolic, Lazaros Mavridis, Oscar M Bautista-Aguilera, et al.Future Medicinal Chemistry|January 31, 2025
Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agentsMilan Beljkas, Dusan Ruzic, Ana Djuric, et al.Pageof 10